Prescription drug · ANDA
Doxazosin NDC 42291-259
Doxazosin mesylate 4 mg/1 · Tablet · Oral · AvKARE
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42291-259-01 | 42291025901 | 100 TABLET in 1 BOTTLE (42291-259-01)Marketed from Apr 9, 2015 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxazosin
- Generic name (nonproprietary)
- doxazosin
- Active ingredients
- Doxazosin mesylate — 4 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- AvKARE
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075580
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 42291-259_4dc7e86f-ca0f-f5d0-e063-6394a90a4eedSPL ID 4dc7e86f-ca0f-f5d0-e063-6394a90a4eedSPL set ID e3d381c1-3b2f-af70-f4e6-08d6202eed25RxCUI 197626, 197627, 197628UNII 86P6PQK0MU
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442291025901followed by a unit qualifier and the quantityPackage 42291-0259-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Doxazosin tablets are an alpha 1 adrenergic antagonist indicated for: Signs and symptoms of Benign Prostatic Hyperplasia (BPH) Treatment of Hypertension 1.1 Benign Prostatic Hyperplasia (BPH) Doxazosin tablets are indicated for the treatment of the signs and symptoms of BPH. 1.2 Hypertension Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should b…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 075580
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-476 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Cardinal Health 107, LLC | 55154-7996 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-043 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | AvKARE | 42291-258 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | AvKARE | 42291-260 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Major Pharmaceuticals | 0904-5522 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Major Pharmaceuticals | 0904-5523 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3298 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3341 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Major Pharmaceuticals | 0904-5524 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-153 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-160 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-878 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | American Health Packaging | 68084-836 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | American Health Packaging | 68084-851 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | American Health Packaging | 68084-862 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4031 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | A-S Medication Solutions | 50090-0701 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | A-S Medication Solutions | 50090-0704 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Apotex Corp. | 60505-0094 |
Showing 20 of 33.